Abiopharma

🔍 BRAWLEY OTIS W (Director)

Company: AGILENT TECHNOLOGIES, INC. (A)

Report Date: 2026-03-19

Detailed Transactions and Holdings:

• Acquired 2,158 shares of Common Stock at $111.75 per share (Direct)
  Date: 2026-03-19 | Code: A | equity_swap_involved: 0 | shares_owned_after: 12,985.62 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 888 shares of Common Stock at $111.75 per share (Direct)
  Date: 2026-03-19 | Code: A | equity_swap_involved: 0 | shares_owned_after: 13,873.62 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer receipt of these shares of common stock.
• F2: 85.693 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock.
• F3: Shares of Agilent Technologies, Inc. common stock held in a deferral account pursuant to the Agilent Technologies, Inc. 2005 Deferred Compensation Plan for Non-Employee Directors.
• REMARKS: See Exhibit 24 - Power of Attorney